Use of fluorescein sodium to obtain histological diagnosis of primary Central nervous system lymphoma ghost tumour despite disappearance on intraoperative magnetic resonance imaging: technical note and review of the literature

References

• Frassanito P, Tamburrini G, Massimi L, Caldarelli M, Di Rocco C. Ghost tumors of the central nervous system: definition, clinical implications, and proposal of classification. World Neurosurg 2015;84:663–70.
   PubMed Web of Science ®Google Scholar
• Coca A, Goday A, Font J, Ingelmo M, Balcells A. Primary cerebral lymphoma: the “ghost tumor”. J Neurosurg 1984;61:202–3.
   PubMed Web of Science ®Google Scholar
• Takekawa H, Hozumi A, Hirata K, Yamazaki K. A spontaneously vanishing primary cerebral lymphoma “ghost tumour”. J Neurol Neurosurg Psychiatry 2008;79:1159.
   PubMed Web of Science ®Google Scholar
• Vaquero J, Martinez R, Rossi E, Lopez R. Primary cerebral lymphoma: the “ghost tumor.” Case report. J Neurosurg 1984;60:174–6.
   PubMed Web of Science ®Google Scholar
• Zaki HS, Jenkinson MD, Du Plessis DG, Smith T, Rainov NG. Vanishing contrast enhancement in malignant glioma after corticosteroid treatment. Acta Neurochir (Wien) 2004;146:841–5.
   PubMed Web of Science ®Google Scholar
• Sakai K, Miyahara T, Tsutsumi K, et al. Spontaneous regression of multicentric pilocytic astrocytoma with CSF dissemination in an adult. Brain Tumor Pathol 2011;28:151–6.
   PubMed Web of Science ®Google Scholar
• Gupta V, Kumar S, Tatke M, Singh AK, Sinha S, Singh D. Disappearing cystic cerebellar medulloblastoma: the ghost tumour. Neurol India 2001;49:291–4.
   PubMed Web of Science ®Google Scholar
• Ono H, Shin M, Takai K, Oya S, Mukasa A, Saito N. Spontaneous regression of germinoma in the pineal region before endoscopic surgery: a pitfall of modern strategy for pineal germ cell tumors. J Neurooncol 2011;103:755–8.
   PubMed Web of Science ®Google Scholar
• Hervey-Jumper SL, Singla N, Gebarski SS, Robertson P, Maher CO. Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects. Pediatr Neurosurg 2013;49:55–9.
   PubMed Web of Science ®Google Scholar
• Fox CP, Phillips EH, Smith J, et al. Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. Br J Haematol 2019Feb;184(3):348–363.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumour of haematopoietic and lymphoid tissues. IARC; 2017.
   Google Scholar
• Rigau V, Zouaoui S, Mathieu-Daudé H, et al. French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol 2011;21:633–44.
   PubMed Web of Science ®Google Scholar
• Manoj N, Arivazhagan A, Mahadevan A, et al. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield. Neurol India 2014;62:19–25.
   PubMed Web of Science ®Google Scholar
• Donaghy M. Shrinking cerebral lymphomas with steroids can cause diagnostic confusion. Pract Neurol 2002;2:218–20.
   Google Scholar
• Haldorsen IS, Espeland A, Larsen JL, Mella O. Diagnostic delay in primary central nervous system lymphoma. Acta Oncol 2005;44:728–34.
   PubMed Web of Science ®Google Scholar
• Önder E, Arikök AT, Önder S, et al. Corticosteriod pre-treated primary CNS lymphoma: a detailed analysis of stereotactic biopsy findings and consideration of interobserver variability. Int J Clin Exp Pathol 2015;8:7798–808.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ. How I treat primary CNS lymphoma. Blood 2011;118:510–22.
   PubMed Web of Science ®Google Scholar
• Weller M. Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 1999;43:237–9.
   PubMed Web of Science ®Google Scholar
• Mokhtari K, Houillier C, Hoang-Xuan K. Brain Biopsy in a patient suffering from primary CNS lymphoma treated with steroids. Eur Assoc Neurooncol Mag 2012;2:95–6.
   Google Scholar
• Barrantes-Freer A, Engel AS, Rodriguez-Villagra OA, et al. Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination. Brain Pathol 2018;28:225–33.
   PubMed Web of Science ®Google Scholar
• Baraniskin A, Deckert M, Schulte-Altedorneburg G, Schlegel U, Schroers R. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system. Br J Haematol 2012;156:421–32.
   PubMed Web of Science ®Google Scholar
• Porter A, Giannini C, Kaufmann T, et al. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol 2008;63:662–7.
   PubMed Web of Science ®Google Scholar
• Binnahil M, Au K, Lu JQ, Wheatley BM, Sankar T. The influence of corticosteroids on diagnostic accuracy of biopsy for primary central nervous system lymphoma. Can J Neurol Sci 2016;43:721–5.
   PubMed Web of Science ®Google Scholar
• Schebesch KM, Brawanski A, Hohenberger C, Hohne J. Fluorescein sodium-guided surgery of malignant brain tumors: history, current concepts, and future projects. Turk Neurosurg 2016;26:185–94.
   PubMed Web of Science ®Google Scholar
• Hendricks BK, Cohen-Gadol AA, Miller JC. Novel delivery methods bypassing the blood-brain and blood-tumor barriers. Neurosurg Focus 2015;38:E10.
   PubMed Web of Science ®Google Scholar
• Diaz RJ, Dios RR, Hattab EM, et al. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance . J Neurosurg 2015; 122:1360–9.
   PubMed Web of Science ®Google Scholar
• Nduom EK, Yang C, Merrill MJ, Zhuang Z, Lonser RR. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. J Neurosurg 2013;119:427–33.
   PubMed Web of Science ®Google Scholar
• Kuroiwa T, Kajimoto Y, Ohta T. Development of a fluorescein operative microscope for use during malignant glioma surgery: a technical note and preliminary report. Surg Neurol 1998;50:41–9.
   PubMedGoogle Scholar
• Kuroiwa T, Kajimoto Y, Ohta T. Surgical management for supratentorial astrocytic tumors. Minim Invasive Neurosurg 1999;42:182–6.
   PubMedGoogle Scholar
• Rey-Dios R, Cohen-Gadol AA. Technical principles and neurosurgical applications of fluorescein fluorescence using a microscope-integrated fluorescence module. Acta Neurochir (Wien) 2013;155:701–6.
   PubMed Web of Science ®Google Scholar
• Schebesch KM, Proescholdt M, Hohne J, et al. Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery-a feasibility study. Acta Neurochir (Wien) 2013;155:693–9.
   PubMed Web of Science ®Google Scholar
• Shinoda J, Yano H, Yoshimura S, et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 2003;99:597–603.
   PubMed Web of Science ®Google Scholar
• Koc K, Anik I, Cabuk B, Ceylan S. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg 2008;22:99–103.
   PubMed Web of Science ®Google Scholar
• Chen B, Wang H, Ge P, et al. Gross total resection of glioma with the intraoperative fluorescence-guidance of fluorescein sodium. Int J Med Sci 2012;9:708–14.
   PubMed Web of Science ®Google Scholar
• Liu JG, Yang SF, Liu YH, Wang X, Mao O. Magnetic resonance diffusion tensor imaging with fluorescein sodium dyeing for surgery of gliomas in brain motor functional areas. Chin Med J (Engl) 2013;126:2418–23.
   PubMed Web of Science ®Google Scholar
• Acerbi F, Broggi M, Schebesch KM, et al. Fluorescein-guided surgery for resection of high-grade gliomas: a multicentric prospective phase II study (FLUOGLIO). Clin Cancer Res 2018;24:52–61.
   PubMed Web of Science ®Google Scholar
• Okuda T, Kataoka K, Kato A. Effectiveness of intraoperative fluorescence for diagnosis of malignant lymphoma. No Shinkei Geka 2008;36:1001–4.
   PubMedGoogle Scholar
• Schebesch KM, Hoehne J, Hohenberger C, et al. Fluorescein sodium-guided resection of cerebral metastases—experience with the first 30 patients. Acta Neurochir (Wien) 2015;157:899–904.
   PubMed Web of Science ®Google Scholar
• Lin FH, Zhang XH, Zhang J, et al. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI. J Neurooncol 2018;139:757–65.
   PubMed Web of Science ®Google Scholar
• Thien A, Rao JP, Ng WH, King NK. The Fluoropen: a simple low-cost device to detect intraoperative fluorescein fluorescence in stereotactic needle biopsy of brain tumors. Acta Neurochir (Wien) 2017;159:371–5.
   PubMed Web of Science ®Google Scholar